Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and perioperative coagulation in radical gastrectomy
ChiCTR-IPR-17011152Phase 4Recruiting
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in perioperative period (2 arms), sponsored by Zhenjiang First People's Hospital. Primary endpoints: Thromboelastography (TEG) parameters, Standard coagulation function tests and 6 more. Started Apr 2017; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
perioperative period
Beyond the preview
Go deeper on ChiCTR-IPR-17011152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011152.